| Name | Title | Contact Details |
|---|---|---|
Michael Bahorich |
Chief Technology Officer | Profile |
Aaron Merrick |
Vice President of Information Technology | Profile |
AmpliPhi Biosciences Corporation (NYSEMKT: APHB) is a biotechnology company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics. AmpliPhi`s product development programs target infections that are often resistant to existing antibiotic treatments. AmpliPhi is collaborating with a number of leading organizations, including Intrexon Corporation (NYSE: XON), the U.S. Army, The Royal Brompton Hospital in London, UK and UK-based University of Leicester, to rapidly advance bacteriophage-based therapies.
Enable Injections was founded in February 2010 in Cincinnati, Ohio by an experienced team of executives and Board Members. The CEO, Michael Hooven, has worked with the Board Members for an average of over 20 years, and this team has started three highly successful medical device companies, including Enable Medical Corporation, AtriCure (ATRC), and Enable Injections.
Forward Intentions Group is a firm specifically equipped in Career Transition representing both organizations and individuals.